XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 1 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2020
Nov. 19, 2020
Dec. 31, 2021
Dec. 31, 2019
Cash flows from operating activities:        
Net income (loss) including non-controlling interests $ (45,962) $ (3,724,611) $ 355,298 $ (90,647)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by operating activities:        
Depreciation, depletion and amortization 16,094 291,115 158,304 787,192
Gain on extinguishment of debt 0 (83,867) 0 (4,312)
(Gain) loss on sale of properties (11) (10,396) (222,806) 4,455
Impairment 0 4,937,143 5 10,257
Deferred income taxes (3,447) (262,926) (977) (32,699)
Derivative instruments 84,615 (233,565) 589,641 106,314
Equity-based compensation expenses 270 31,315 15,476 33,607
Non-cash reorganization items, net 0 (809,036) 0 0
Deferred financing costs amortization and other 6,824 41,811 12,992 27,263
Working capital and other changes:        
Change in accounts receivable, net 68,322 96,436 (184,605) 13,729
Change in inventory 1,902 (4,005) 2,168 (5,893)
Change in prepaid expenses (2,976) 1,674 5,605 325
Change in accounts payable, interest payable and accrued liabilities (24,573) (62,694) 184,517 53,051
Change in other assets and liabilities, net (5,803) (5,458) (1,482) (9,789)
Net cash provided by operating activities 95,255 202,936 914,136 892,853
Cash flows from investing activities:        
Capital expenditures (9,805) (332,007) (212,820) (869,221)
Acquisitions 0 0 (590,097) (21,009)
Proceeds from sale of properties 0 15,188 376,081 42,376
Costs related to sale of properties 0 0 (2,926) 0
Derivative settlements (76) 224,416 (270,118) 19,098
Derivative modifications 0 0 (220,889) 0
Net cash used in investing activities (9,881) (92,403) (920,769) (828,756)
Cash flows from financing activities:        
Proceeds from revolving credit facilities 29,000 686,189 399,500 1,982,000
Principal payments on revolving credit facilities (114,500) (686,189) (906,500) (1,972,500)
Repurchase of senior unsecured notes 0 (68,060) 0 (45,790)
Proceeds from issuance of senior unsecured notes 0 0 850,000 0
Deferred financing costs 0 (7,260) (22,251) (1,052)
Debtor-in-possession credit facility fees 0 (5,853) 0 0
Proceeds from issuance of OMP common units, net of offering costs 0 0 86,467 0
Common control transaction costs 0 0 (5,675) 0
Purchases of treasury stock 0 (2,756) (100,000) (4,856)
Dividends paid 0 0 (111,905) 0
Distributions to non-controlling interests 0 (24,080) (28,720) (21,270)
Payments on finance lease liabilities (202) (1,989) (1,161) (2,382)
Proceeds from warrants exercised 0 0 1,435 0
Other 0 0 0 (418)
Net cash provided by (used in) financing activities (85,702) (109,998) 161,190 (66,268)
Increase (decrease) in cash, cash equivalents and restricted cash (328) 535 154,557 (2,171)
Cash, cash equivalents and restricted cash:        
Beginning of period 20,554 20,019 20,226 22,190
End of period 20,226 20,554 174,783 20,019
Supplemental cash flow information:        
Cash paid for interest, net of capitalized interest 2,411 152,416 41,603 155,833
Cash paid for income taxes 1 109 20,000 111
Cash received for income tax refunds 28 282 0 146
Cash paid for reorganization items 0 22,205 0 0
Supplemental non-cash transactions:        
Change in accrued capital expenditures 7,938 (107,725) 8,304 (82,414)
Change in asset retirement obligations 377 (10,268) 14,724 4,917
Note receivable from divestiture 0 0 2,900 0
Contingent consideration (Permian Basin Sale) $ 0 $ 0 $ 32,860 $ 0